Sternal Closure Systems Market Overview
The Sternal Closure Systems Market is witnessing steady growth as cardiac surgery volumes increase and healthcare providers place greater emphasis on reducing postoperative complications and improving sternal stability. The aging population, rising prevalence of cardiovascular diseases, and growing adoption of rigid fixation technologies are supporting demand for advanced sternal closure solutions.
According to the Market Research Future report updated August 24, 2026, the Sternal Closure Systems Market was valued at USD 2.82 Billion in 2025 and is projected to grow from USD 2.97 Billion in 2026 to USD 4.57 Billion by 2035, registering a CAGR of 4.90% during the forecast period from 2026 to 2035. North America held the largest regional share at approximately 38.5% in 2025, while Asia-Pacific is projected to be the fastest-growing region at a 10.4% CAGR. Wires represented the largest product segment with approximately 48% of market share, while Plates and Screws are the fastest-growing product category at an 8.5% CAGR. Median Sternotomy accounted for roughly 72% of procedure demand, while Bilateral Thoracosternotomy is projected to grow at a 10.5% CAGR. Stainless Steel represented approximately 60% of the closure-material market, while Titanium is the fastest-growing material at a 9.7% CAGR. Tertiary Care Hospitals held the largest end-user share at 47.5%, while Ambulatory Surgery Centers are expanding at a 10.3% CAGR.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
Key players driving innovation and competitiveness in the Sternal Closure Systems Market include:
Zimmer Biomet
B. Braun Melsungen
DePuy Synthes
KLS Martin Group
A&E Medical Corporation
Acute Innovations
IDEAR S.r.l.
Jace Medical
Able Medical Devices
Praesidia SRL
The Sternal Closure Systems Market is being shaped by the growing adoption of rigid fixation technologies, clinical evidence supporting improved sternal stability, and value-based healthcare models. Hospitals are increasingly evaluating closure technologies based on their ability to reduce complications and readmissions rather than relying solely on upfront device costs. Advances in titanium systems, patient-specific implants, bioresorbable materials, and digitally assisted surgical planning are creating new opportunities for manufacturers.
The Sternal Closure Systems Market can be segmented by product type, procedure, closure material, and end user. By product type, Wires dominate with approximately 48% share because of their low cost and extensive surgeon familiarity, while Plates and Screws are the fastest-growing segment as rigid fixation gains adoption among high-risk patients. By procedure, Median Sternotomy holds the largest share at approximately 72%, while Bilateral Thoracosternotomy is growing rapidly. By closure material, Stainless Steel leads with approximately 60% share, while Titanium is the fastest-growing material due to its biocompatibility and favorable imaging characteristics. By end user, Tertiary Care Hospitals account for the largest share at 47.5%, while Ambulatory Surgery Centers are projected to experience the fastest growth.
Significant opportunities are emerging from bioresorbable closure platforms, AI-guided preoperative planning, patient-specific 3D-printed closure hardware, robotic-assisted sternotomy closure, and innovative procurement models. Expansion of cardiac surgery infrastructure in emerging markets, particularly across Asia-Pacific, is also creating opportunities for advanced closure technologies. Manufacturers that combine clinical evidence, surgeon training, digital planning capabilities, and flexible procurement models can strengthen adoption in both mature and developing markets.
Recent Developments and Market Trends:
Rigid plate-and-screw fixation is gaining momentum as clinical evidence increasingly supports its ability to improve sternal stability and reduce complications in high-risk cardiac surgery patients.
Titanium closure systems are attracting greater interest because of their biocompatibility, lower imaging artifact, and potential advantages for patients requiring postoperative diagnostic imaging.
Bioresorbable sternal closure platforms are emerging as a next-generation technology designed to reduce the need for permanent hardware and secondary removal procedures.
AI-guided preoperative planning and patient-specific 3D-printed closure hardware are creating opportunities to optimize plate positioning, screw trajectories, and anatomical fit.
The expansion of cardiac surgery infrastructure across Asia-Pacific is accelerating demand for modern closure technologies as new cardiac centers and government healthcare programs increase procedure capacity.
Reasons to Buy the Report:
Gain comprehensive insights into the global Sternal Closure Systems Market size, growth rate, and forecast through 2035.
Understand the major product type, procedure, closure-material, and end-user segments shaping market demand.
Evaluate regional opportunities across North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
Identify leading companies, competitive strategies, rigid fixation innovations, material developments, and emerging market opportunities.
Use strategic market intelligence to assess investment opportunities, product development, competitive positioning, and future growth prospects.
Future Outlook:
The Sternal Closure Systems Market is expected to maintain steady growth through 2035 as cardiac surgery volumes increase, populations age, and healthcare providers increasingly prioritize postoperative stability and complication reduction. Wires will remain the dominant product category because of their low cost, established supply chains, and long-standing surgeon familiarity, while Plates and Screws are expected to experience the fastest growth as rigid fixation gains clinical and economic acceptance, particularly among obese, diabetic, and other high-risk patients. Median Sternotomy will continue to represent the largest procedure category because of its widespread use in CABG and valve procedures, while Bilateral Thoracosternotomy is projected to grow rapidly in complex congenital and oncology cases. Stainless Steel will retain its leading position because of cost efficiency and established manufacturing infrastructure, while Titanium is expected to experience faster growth because of its biocompatibility and favorable MRI characteristics. Tertiary Care Hospitals will remain the largest end-user segment, while Ambulatory Surgery Centers are positioned for rapid growth as minimally invasive cardiac procedures and outpatient surgical models expand. North America is expected to maintain regional leadership, supported by advanced cardiac surgery infrastructure, value-based reimbursement, and strong adoption of innovative fixation systems, while Asia-Pacific is projected to remain the fastest-growing region at a 10.4% CAGR due to new cardiac centers, government healthcare programs, and increasing cardiovascular disease burden. Continued innovation in bioresorbable materials, AI-guided planning, 3D-printed implants, smart fixation, and robotic-assisted closure is expected to support the market’s progression toward USD 4.57 Billion by 2035 at a CAGR of 4.90%.
➤➤Explore Our Latest Related Reports:
